Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

NCT05954910

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, China
View all 29 locations
View Trial Details
Recruiting

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

NCT05722886

Conditions
Haematological Malignancy, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details
Recruiting

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

NCT05952024

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site Stamford, Connecticut, United States
View all 57 locations
View Trial Details

Related conditions